BDBM250021 US10005782, Compound 143::US9447106, 143::US9556188, Compound 143

SMILES: CC1(CNC(=O)C=C)CCNc2c(C(N)=O)c(nn12)-c1ccc(Oc2ccccc2)cc1

InChI Key: InChIKey=OSFVFJLOFLIGBP-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 250021   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250021 (US10005782, Compound 143 | US9447106, 143 | US9556...) Show SMILES CC1(CNC(=O)C=C)CCNc2c(C(N)=O)c(nn12)-c1ccc(Oc2ccccc2)cc1 Show InChI InChI=1S/C24H25N5O3/c1-3-19(30)27-15-24(2)13-14-26-23-20(22(25)31)21(28-29(23)24)16-9-11-18(12-10-16)32-17-7-5-4-6-8-17/h3-12,26H,1,13-15H2,2H3,(H2,25,31)(H,27,30)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.890	n/a	n/a	n/a	n/a	n/a	25
BeiGene, Ltd. US Patent					Assay Description Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfe...				US Patent US9447106 (2016) BindingDB Entry DOI: 10.7270/Q21Z439C
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250021 (US10005782, Compound 143 | US9447106, 143 | US9556...) Show SMILES CC1(CNC(=O)C=C)CCNc2c(C(N)=O)c(nn12)-c1ccc(Oc2ccccc2)cc1 Show InChI InChI=1S/C24H25N5O3/c1-3-19(30)27-15-24(2)13-14-26-23-20(22(25)31)21(28-29(23)24)16-9-11-18(12-10-16)32-17-7-5-4-6-8-17/h3-12,26H,1,13-15H2,2H3,(H2,25,31)(H,27,30)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.890	n/a	n/a	n/a	n/a	n/a	n/a
Wyeth Research					Assay Description Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfe...				Bioorg Med Chem 17: 7755-68 (2009) BindingDB Entry DOI: 10.7270/Q29889BD
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250021 (US10005782, Compound 143 | US9447106, 143 | US9556...) Show SMILES CC1(CNC(=O)C=C)CCNc2c(C(N)=O)c(nn12)-c1ccc(Oc2ccccc2)cc1 Show InChI InChI=1S/C24H25N5O3/c1-3-19(30)27-15-24(2)13-14-26-23-20(22(25)31)21(28-29(23)24)16-9-11-18(12-10-16)32-17-7-5-4-6-8-17/h3-12,26H,1,13-15H2,2H3,(H2,25,31)(H,27,30)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.890	n/a	n/a	n/a	n/a	n/a	25
BeiGene, Ltd. US Patent					Assay Description Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfe...				US Patent US9556188 (2017) BindingDB Entry DOI: 10.7270/Q26Q2082
					More data for this Ligand-Target Pair